SavedAdd your journal

Journals / Archives of Rheumatology / 2022 / Cilt: 37 - Sayı: 1

Reactivation of inflammatory monoarthritis during dupilumab treatment used for prurigo nodularis

Zehra ÖZSOY
Fatma Bilge ERGEN
Duygy GÜLSEREN
Ecem BOSTAN
Pages
148–149
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

ÖZSOY, Z., ERGEN, F. B., GÜLSEREN, D., BOSTAN, E. (2022). Reactivation of inflammatory monoarthritis during dupilumab treatment used for prurigo nodularis. Archives of Rheumatology, Cilt: 37 - Sayı: 1, 148–149. https://ajindex.com/articles/447983

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (4)

  1. Nettis E, Patella V, Brancaccio R, Detoraki C, Di Leo E, Incorvaia C, et al. Efficacy of dupilumab in concomitant atopic dermatitis and chronic rhinosinusitis with nasal polyps: A preliminary study. Allergy Asthma Immunol Res 2021;13:347-9
  2. Ariëns LFM, van der Schaft J, Spekhorst LS, Bakker DS, Romeijn GLE, Kouwenhoven TA, et al. Dupilumab shows long-term effectiveness in a large cohort of treatment-refractory atopic dermatitis patients in daily practice: 52-Week results from the Dutch BioDay registry. J Am Acad Dermatol 2021;84:1000-9. 3. de Wijs LEM, van der Waa JD, de Jong PHP, Hijnen DJ. Acute arthritis and arthralgia as an adverse drug reaction to dupilumab. Clin Exp Dermatol 2020;45:262-3
  3. Willsmore ZN, Woolf RT, Hughes C, Menon B, Kirkham B, Smith CH, et al. Development of inflammatory arthritis and enthesitis in patients on dupilumab: A case series. Br J Dermatol 2019;181:1068-70
  4. Dong C, Fu T, Ji J, Li Z, Gu Z. The role of interleukin-4 in rheumatic diseases. Clin Exp Pharmacol Physiol 2018;45:747-54.